A functional proteogenomic analysis of endometrioid and clear cell carcinomas using reverse phase protein array and mutation analysis: protein expression is histotype-specific and loss of ARID1A/BAF250a is associated with AKT phosphorylation
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A functional proteogenomic analysis of endometrioid and clear cell carcinomas using reverse phase protein array and mutation analysis: protein expression is histotype-specific and loss of ARID1A/BAF250a is associated with AKT phosphorylation
Authors
Keywords
Ovarian cancer, Proteomics, <em class=EmphasisTypeItalic >ARID1A</em>/BAF250a, <em class=EmphasisTypeItalic >PIK3CA</em> mutation, AKT, Phosphorylation
Journal
BMC CANCER
Volume 14, Issue 1, Pages -
Publisher
Springer Nature
Online
2014-02-22
DOI
10.1186/1471-2407-14-120
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Oncometabolites: linking altered metabolism with cancer
- (2013) Ming Yang et al. JOURNAL OF CLINICAL INVESTIGATION
- The clinicopathologic significance of p53 and BAF-250a (ARID1A) expression in clear cell carcinoma of the endometrium
- (2013) Oluwole Fadare et al. MODERN PATHOLOGY
- Identification and Quantification of AKT Isoforms and Phosphoforms in Breast Cancer Using a Novel Nanofluidic Immunoassay
- (2013) Demetris C. Iacovides et al. MOLECULAR & CELLULAR PROTEOMICS
- ARID1A Alterations Are Associated with FGFR3-Wild Type, Poor-Prognosis, Urothelial Bladder Tumors
- (2013) Cristina Balbás-Martínez et al. PLoS One
- Proteomic Classification of Breast Cancer
- (2012) Dalia Kamel et al. CURRENT DRUG TARGETS
- Applications of imaged capillary isoelectric focussing technique in development of biopharmaceutical glycoprotein-based products
- (2012) Carrie L. Anderson et al. ELECTROPHORESIS
- Whole-exome sequencing combined with functional genomics reveals novel candidate driver cancer genes in endometrial cancer
- (2012) H. Liang et al. GENOME RESEARCH
- Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case–control studies
- (2012) Celeste Leigh Pearce et al. LANCET ONCOLOGY
- ARID1A, a Factor That Promotes Formation of SWI/SNF-Mediated Chromatin Remodeling, Is a Tumor Suppressor in Gynecologic Cancers
- (2011) B. Guan et al. CANCER RESEARCH
- Clear cell carcinoma of the ovary: A report from the first Ovarian Clear Cell Symposium, June 24th, 2010
- (2011) Michael S. Anglesio et al. GYNECOLOGIC ONCOLOGY
- The association between endometriosis and gynecological cancers and breast cancer: A review of epidemiological data
- (2011) Peter Svenssen Munksgaard et al. GYNECOLOGIC ONCOLOGY
- First-Line Therapy in Ovarian Cancer Trials
- (2011) Tate Thigpen et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Loss of ARID1A-Associated Protein Expression is a Frequent Event in Clear Cell and Endometrioid Ovarian Cancers
- (2011) William J. Lowery et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- TP53 mutations in serous tubal intraepithelial carcinoma and concurrent pelvic high-grade serous carcinoma-evidence supporting the clonal relationship of the two lesions
- (2011) Elisabetta Kuhn et al. JOURNAL OF PATHOLOGY
- PI3K Pathway Mutations and PTEN Levels in Primary and Metastatic Breast Cancer
- (2011) A. M. Gonzalez-Angulo et al. MOLECULAR CANCER THERAPEUTICS
- High Frequency of PIK3R1 and PIK3R2 Mutations in Endometrial Cancer Elucidates a Novel Mechanism for Regulation of PTEN Protein Stability
- (2011) Lydia W.T. Cheung et al. Cancer Discovery
- Functional Proteomic Analysis of Advanced Serous Ovarian Cancer Using Reverse Phase Protein Array: TGF- Pathway Signaling Indicates Response to Primary Chemotherapy
- (2010) M. S. Carey et al. CLINICAL CANCER RESEARCH
- Randomized Phase II Trial of Paclitaxel Plus Carboplatin Therapy Versus Irinotecan Plus Cisplatin Therapy as First-Line Chemotherapy for Clear Cell Adenocarcinoma of the Ovary
- (2010) Satoshi Takakura et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Prognostic Relevance of Uncommon Ovarian Histology in Women With Stage III/IV Epithelial Ovarian Cancer
- (2010) Helen J. Mackay et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Differences in Tumor Type in Low-stage Versus High-stage Ovarian Carcinomas
- (2010) Martin Köbel et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- ARID1AMutations in Endometriosis-Associated Ovarian Carcinomas
- (2010) Kimberly C. Wiegand et al. NEW ENGLAND JOURNAL OF MEDICINE
- Frequent Mutations of Chromatin Remodeling Gene ARID1A in Ovarian Clear Cell Carcinoma
- (2010) Siân Jones et al. SCIENCE
- Frequent Activating Mutations of PIK3CA in Ovarian Clear Cell Carcinoma
- (2009) Kuan-Ting Kuo et al. AMERICAN JOURNAL OF PATHOLOGY
- AKT-Independent Signaling Downstream of Oncogenic PIK3CA Mutations in Human Cancer
- (2009) Krishna M. Vasudevan et al. CANCER CELL
- An Integrative Genomic and Proteomic Analysis of PIK3CA, PTEN, and AKT Mutations in Breast Cancer
- (2008) K. Stemke-Hale et al. CANCER RESEARCH
- PTEN promoter methylation and LOH of 10q22–23 locus in PTEN expression of ovarian clear cell adenocarcinomas
- (2008) Chih-Ming Ho et al. GYNECOLOGIC ONCOLOGY
- Ovarian Carcinoma Subtypes Are Different Diseases: Implications for Biomarker Studies
- (2008) Martin Köbel et al. PLOS MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now